	Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patients. J Natl Cancer Cent Tan F, Jiang Y, Duan J, Li R, Cao J, Jiang W, Li Q, Zhang G, Duan J, Wang Y, Wang Z, Li W, Ying J, Wang J, Bi N, He J. PMID: 42007220 [PubMed - as supplied by publisher]
	Radiology artificial intelligence for prioritized imaging and diagnosis of lung cancer: qualitative interview analysis of stakeholder perspectives in Northern Ireland. Front Med (Lausanne) Rainey C, McFadden S, Gill A. PMID: 42006881 [PubMed - as supplied by publisher]
	Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality Registry. JTO Clin Res Rep Stirling RG, Tissera S, Zeng J, Lloyd M, Krishnaprasad K, Briggs L, Lesage J, Wood T, Underhill C, Parakh S, Irving L, Faisal W, Blum R, Richardson G, Parente P, Caldecott M, Olesen I, Torres J, Samuel E, Lyne C, See K, Langton D, John T, Wright GM, Conron M, Bartlett J, Atkin N, Moore M, Adabi G, Clegg L, Zeps N, Harden S, McQuilten Z, Zalcberg J. PMID: 42006279 [PubMed]
	Financial hardship among patients with lung cancer and their family caregivers: A comparative study of two institution-based samples from Hong Kong and Mainland China. Asia Pac J Oncol Nurs Jia S, He J, Ho MH, Cheung DST, Lin CC. PMID: 42006094 [PubMed - as supplied by publisher]
	Challenges in Diagnosis of Lepidic Subtype in Lung Cancer According to W.H.O Classification: A Case Report. Br J Biomed Sci Pham Nguyen C, Phan LT, Phan PT, Phan DQT, Pham Nguyen T, Dang TV. PMID: 42005588 [PubMed - as supplied by publisher]
	The Evolving Role of Local Radiotherapy in the Management of Oligometastatic Non-Small Cell Lung Cancer. Cancer Manag Res Zhang X, Liu M, Wang Z. PMID: 42005445 [PubMed - as supplied by publisher]
	The Role of Complement Anaphylatoxins (C3a and C5a) in Non-small Cell Lung Cancer: A Systematic Review. Cureus Skarentzos K, Karagialani DK, Mitros V, Economopoulou P, Foukas P. PMID: 42005226 [PubMed - as supplied by publisher]
	Cryoablation as a Treatment Option for Early-Stage Primary Non-Small Cell Lung Cancer and Lung Metastases: A Narrative Review of Recent Literature. J Patient Cent Res Rev Karupakula E, Nemr C, Chen J, Hampole A. PMID: 42004807 [PubMed - as supplied by publisher]
	The potential survival gain and cost-effectiveness of circulating tumor DNA-guided treatment switching in advanced non-small cell lung cancer: A simulation modeling study. J Liq Biopsy Jansen JP, Douglas MP, Phillips KA. PMID: 42004688 [PubMed - as supplied by publisher]
	Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise study. ESMO Real World Data Digit Oncol Lay-Flurrie S, Greystoke A, Rault C, Wolf A, Riaz M, Leal C, de Abreu E Lima F, Van Naarden Braun K, Evans-Cheung T, Glassberg MB, Eccles LJ, Cheeseman S, Chouaid C, Baas P. PMID: 42004489 [PubMed - as supplied by publisher]
	Real-world outcomes of consolidative radiotherapy following first-line chemo-immunotherapy in metastatic non-small cell lung cancer: a retrospective cohort study. Am J Cancer Res Qiao Z, Pang L, Zheng H. PMID: 42004069 [PubMed - as supplied by publisher]
	Association between perioperative opioid consumption and postoperative outcomes in lung cancer surgery: evidence from a retrospective study with inflammatory and immune biomarker analysis. Am J Cancer Res Li R, Ma W. PMID: 42004068 [PubMed]
	Efficacy of chemotherapy combined with immune checkpoint inhibitors for advanced non-small cell lung cancer and construction and validation of a prognostic model: a multicenter retrospective cohort study. Am J Cancer Res Gong C, Lv F, Xiong B, Li L, Wu M, Luo L. PMID: 42004067 [PubMed]
	Predictive value of the systemic immune-inflammation index and geriatric nutritional risk index on the efficacy of immunotherapy and survival prognosis in advanced non-small cell lung cancer: a retrospective study. Am J Cancer Res Wu J, Duan Z, Qian J, Hu C, Chen C, Li Y, Cao T. PMID: 42004059 [PubMed - as supplied by publisher]
	Association between dynamic trajectories of serum tumor markers and survival outcomes in patients with extensive-stage small cell lung cancer: a retrospective cohort study. Biomark Med Jia B, Wu B, Chen S, Wang Y, Hu Q, Li P, Qin Y. PMID: 42003799 [PubMed - as supplied by publisher]
	Combining cutting edge computational and experimental methods for targeting kras mutations in non-small cell lung cancer. Expert Opin Drug Discov Samudrala R, Bruggemann L, Falls Z, Mahajan SD. PMID: 42003513 [PubMed - as supplied by publisher]
	Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II Trial. Int J Cancer Niedermaier B, Bochtler T, Eichhorn F, Griffo R, Klotz LV, Allgäuer M, Stenzinger A, Bischoff H, Schneider MA, Christopoulos P, Haberkorn U, Heussel CP, Zoernig I, Herth FJF, Thomas M, Rölle A, Winter H, Benner A, Jaeger D, Eichhorn ME. PMID: 42003237 [PubMed - as supplied by publisher]
	Corrigendum to: Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune Regulation. Comb Chem High Throughput Screen Luo Y, Zhang M, Wang Z, Li Z, Chen X, Cao J, Que J, Chen L, Deng X. PMID: 42003235 [PubMed - indexed for MEDLINE]
	An Interpretable Radiomics Model Based on Multi-DLCT Images for Differentiating Benign and Malignant Solid Solitary Pulmonary Nodules. Med Phys Lin Z, Huang P, Xiao S, Fan B, Tan Y, Luo S, Wang Y, Yu X, Zhang D, Zuo M. PMID: 42003192 [PubMed - indexed for MEDLINE]
	Sequential thoracic radiotherapy following immunotherapy in advanced non-small cell lung cancer: a real-world retrospective cohort study on efficacy and safety. BMC Cancer Ma HL, Zhao MD, Meng JM, Peng F, Peng J. PMID: 42002739 [PubMed - as supplied by publisher]

Articles 1 - 20 / 158054

Page 1 of 7903



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy